@ziyoujituan.bsky.social
Yes, it said “ complete” on 2025.10.02, while change to “terminate” on 2025.10.29, in addition, Merck started a new phase I for MK-4646, NCT07199452
November 3, 2025 at 6:14 PM
Yes, it said “ complete” on 2025.10.02, while change to “terminate” on 2025.10.29, in addition, Merck started a new phase I for MK-4646, NCT07199452
The phase 2 of Budigalimab （NCT06032546）changed status to “Terminate” on 2025.10.25
November 3, 2025 at 5:58 PM
The phase 2 of Budigalimab （NCT06032546）changed status to “Terminate” on 2025.10.25